Ironwood Pharmaceuticals | IRWD - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Acadia Pharmaceuticals USD 4.33B 537M 2026-06
Akebia Therapeutics USD 427M 297M 2025-12
Almirall EUR 2.76B 472.53M 2025-12
Alnylam Pharmaceuticals USD 40.19B 3.96B 2026-06
Amarin USD 290M 51M 2025-12
Ardelyx USD 1.48B 63M 2026-03
Astellas Pharma JPY 3.94T 622.52B 2026-06
AstraZeneca USD 289.99B 11.26B 2026-06
Charles River Laboratories USD 10.39B 2.54B 2026-06
Coherus Biosciences USD 172M 19M 2025-12
Emergent BioSolutions USD 125M 51M 2023-12
Halozyme Therapeutics USD 9.28B 1.63B 2026-06
Incyte USD 22.65B 3.92B 2026-06
Karyopharm Therapeutics USD 126M 9M 2026-03
Lexicon Pharmaceuticals USD 418M 73M 2025-12
MacroGenics USD 184M 82M 2026-03
Pacira USD 998M 83M 2026-06
Sarepta Therapeutics USD 1.9B 388M 2026-06
Takeda JPY 8.2T 809.7B 2026-06
Ultragenyx Pharmaceutical USD 3.29B 1.23B 2026-06
Vanda Pharmaceuticals USD 279M 6M 2024-12